Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Blüher (2009)
Adipose tissue dysfunction in obesity.Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 117 6
I. Myara, C. Alamowitch, O. Michel, D. Heudes, J. Bariéty, B. Guy-grand, J. Chevalier (2003)
Lipoprotein oxidation and plasma vitamin E in nondiabetic normotensive obese patients.Obesity research, 11 1
M. Mastorikou, B. Mackness, Yifen Liu, Mike Mackness (2008)
Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxidesDiabetic Medicine, 25
L. Bajnok, E. Csongrádi, I. Seres, Z. Varga, S. Jeges, A. Peti, Z. Karányi, A. Juhasz, E. Mezősi, E. Nagy, G. Paragh (2008)
Relationship of adiponectin to serum paraoxonase 1.Atherosclerosis, 197 1
Delma Nieves, M. Cnop, B. Retzlaff, C. Walden, J. Brunzell, R. Knopp, S. Kahn (2003)
The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat.Diabetes, 52 1
E. Nishio, Yasuhiro Watanabe (1997)
Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme's free thiols.Biochemical and biophysical research communications, 236 2
K. Feingold, R. Memon, A. Moser, C. Grunfeld (1998)
Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response.Atherosclerosis, 139 2
Jakubowski (2000)
Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylationJ Biol Chem, 275
A. Ozenoglu, H. Balcı, S. Uğurlu, E. Çağlar, H. Uzun, Cihat Şarkış, Can Gunay, Engin E (2008)
The Relationships of Leptin, Adiponectin Levels and Paraoxonase Activity with Metabolic and Cardiovascular Risk Factors in Females Treated with Psychiatric DrugsClinics (Sao Paulo, Brazil), 63
M. Navab, G. Anantharamaiah, S. Reddy, B. Lenten, B. Ansell, A. Fogelman (2006)
Mechanisms of Disease: proatherogenic HDL—an evolving fieldNature Clinical Practice Endocrinology &Metabolism, 2
Y. Kumon, T. Suehiro, Y. Ikeda, K. Hashimoto (2003)
Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1β and tumor necrosis factor-α, but is upregulated by interleukin-6Life Sciences, 73
M. Rosenblat, J. Vaya, D. Shih, M. Aviram (2005)
Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine.Atherosclerosis, 179 1
V. Bowry, K. Stanley, R. Stocker (1992)
High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors.Proceedings of the National Academy of Sciences of the United States of America, 89 21
Y. Kumon, T. Suehiro, Y. Ikeda, K. Hashimoto (2003)
Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1beta and tumor necrosis factor-alpha, but is upregulated by interleukin-6.Life sciences, 73 22
Ferretti (2005)
Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese femalesJ Clin Endocrinol Metab, 90
G. Ferretti, T. Bacchetti, D. Busni, R. Rabini, G. Curatola (2004)
Protective effect of paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients.The Journal of clinical endocrinology and metabolism, 89 6
L. Bajnok, I. Seres, Z. Varga, S. Jeges, A. Peti, Z. Karányi, A. Juhasz, E. Csongrádi, E. Mezősi, E. Nagy, G. Paragh (2007)
Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.Metabolism: clinical and experimental, 56 11
K. Kuehl, S. Yeroushalmy, P. Holloway (1980)
Modulation of membrane composition of swine vascular smooth muscle cells by homologous lipoproteins in culture.Biochimica et biophysica acta, 600 3
L. Costa, A. Vitalone, T. Cole, C. Furlong (2005)
Modulation of paraoxonase (PON1) activity.Biochemical pharmacology, 69 4
B. Mackness, P. Durrington, P. McElduff, J. Yarnell, N. Azam, M. Watt, M. Mackness (2003)
Low Paraoxonase Activity Predicts Coronary Events in the Caerphilly Prospective StudyCirculation: Journal of the American Heart Association, 107
Ü. Mutlu-Türkoğlu, S. Öztezcan, A. Telci, Y. Orhan, G. Aykaç-toker, A. Sivas, M. Uysal (2003)
An increase in lipoprotein oxidation and endogenous lipid peroxides in serum of obese womenClinical and Experimental Medicine, 2
G. Ferretti, T. Bacchetti, C. Moroni, A. Vignini, G. Curatola (2003)
Copper-induced oxidative damage on astrocytes: protective effect exerted by human high density lipoproteins.Biochimica et biophysica acta, 1635 1
M. Aviram, M. Rosenblat, S. Billecke, J. Erogul, R. Sorenson, C. Bisgaier, R. Newton, B. Du (1999)
Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.Free radical biology & medicine, 26 7-8
A. Graham, D. Hassall, S. Rafique, J. Owen (1997)
Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein.Atherosclerosis, 135 2
G. Ferretti, T. Bacchetti, A. Nègre-Salvayre, R. Salvayre, N. Dousset, G. Curatola (2006)
Structural modifications of HDL and functional consequences.Atherosclerosis, 184 1
A. Mertens, P. Verhamme, J. Bielicki, M. Phillips, R. Quarck, W. Verreth, D. Stengel, E. Ninio, M. Navab, B. Mackness, M. Mackness, P. Holvoet (2003)
Increased Low-Density Lipoprotein Oxidation and Impaired High-Density Lipoprotein Antioxidant Defense Are Associated With Increased Macrophage Homing and Atherosclerosis in Dyslipidemic Obese Mice: LCAT Gene Transfer Decreases AtherosclerosisCirculation: Journal of the American Heart Association, 107
Takayuki Sasahara, Takeshi Yamashita, D. Sviridov, Noel Fidge, P. Nestel (1997)
Altered properties of high density lipoprotein subfractions in obese subjects.Journal of lipid research, 38 3
M. Mackness, S. Arrol, C. Abbott, P. Durrington (1993)
Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.Atherosclerosis, 104 1-2
M. Bradford (1976)
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Analytical biochemistry, 72
Tomoko Kljno, M. Hozumi, T. Morinobu, T. Murata, Mingci Zheng, H. Tamai (1998)
Antioxidant vitamin levels in plasma and low density lipoprotein of obese girls.Free radical research, 28 1
H. Jakubowski (2000)
Calcium-dependent Human Serum Homocysteine Thiolactone HydrolaseThe Journal of Biological Chemistry, 275
A. Watson, J. Berliner, S. Hama, B. Du, K. Faull, A. Fogelman, M. Navab (1995)
Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.The Journal of clinical investigation, 96 6
J. Teiber, S. Billecke, B. Du, D. Draganov (2007)
Estrogen esters as substrates for human paraoxonases.Archives of biochemistry and biophysics, 461 1
0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(3):1728–1733 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/jc.2004-0486 Paraoxonase Activity in High-Density Lipoproteins: A Comparison between Healthy
Gianna Ferretti, T. Bacchetti, E. Marotti, G. Curatola (2003)
Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity.Metabolism: clinical and experimental, 52 2
S. Olusi (2002)
Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humansInternational Journal of Obesity, 26
L. Jaouad, C. Milochevitch, A. Khalil (2003)
PON1 Paraoxonase Activity is Reduced During HDL Oxidation and is an Indicator of HDL Antioxidant CapacityFree Radical Research, 37
S. Salmon, C. Maziére, M. Auclair, L. Théron, R. Santus, J. Mazière (1992)
Malondialdehyde modification and copper-induced autooxidation of high-density lipoprotein decrease cholesterol efflux from human cultured fibroblasts.Biochimica et biophysica acta, 1125 2
(1997)
Evidence for a paraoxonaseindependent inhibition of low-density lipoprotein oxidation by high-density lipoprotein
Gianna Ferretti, T. Bacchetti, C. Marchionni, L. Caldarelli, G. Curatola (2001)
Effect of glycation of high density lipoproteins on their physicochemical properties and on paraoxonase activityActa Diabetologica, 38
Prof. Yudkin, J. Yudkin (2007)
Inflammation, Obesity, and the Metabolic SyndromeHormone and Metabolic Research, 39
N. Santanam, S. Parthasarathy (2007)
Aspirin is a substrate for paraoxonase-like activity: implications in atherosclerosis.Atherosclerosis, 191 2
A. Klimov, K. Kozhevnikova, A. Kuzmin, A. Kuznetsov, E. Belova (2001)
On the Ability of High Density Lipoproteins to Remove Phospholipid Peroxidation Products from Erythrocyte MembranesBiochemistry (Moscow), 66
High‐density lipoproteins (HDLs) play a key role in the protection against oxidative damage. The enzyme paraoxonase‐1 (PON1) associated at the surface of HDL modulates the antioxidant and anti‐inflammatory role of HDL. Previous studies have demonstrated a decrease of serum PON in obese patients. The aim of this study was to investigate whether modifications of PON1 activity reflect in a different ability to protect and/or repair biological membranes against oxidative damage. Thirty obese patients at different grades of obesity (BMI ranging from 30.4 to 64.0 kg/m2) and 62 age‐matched control subjects (BMI <25 kg/m2) were included in the study. The ability of HDL to protect membranes against oxidative damage was studied using erythrocyte membranes oxidized with 2,2‐azobis(2 amidinopropane)dihydrochloride (AAPH) (ox‐membrane). The membrane lipid hydroperoxide levels were evaluated after the incubation of ox‐membranes in the absence or in the presence of HDL of controls or obese patients. The results confirm that HDL exerts a protective effect against lipid peroxidation. The ability of HDL to repair erythrocyte membranes was positively correlated with HDL‐PON activity and negatively correlated with lipid hydroperoxide levels in HDL. These results suggest that PON modulates the HDL repairing ability. HDL from obese patients repaired less efficiently erythrocyte membranes against oxidative damage with respect to HDL from healthy subjects. A negative relationship has been established between BMI of obese patients and the protective effect of HDL. In conclusion, the decrease of HDL‐PON activity and the lower HDL protective action against membrane peroxidation in obese patients could contribute to accelerate the cellular oxidative damage and arteriosclerosis in obesity.
Obesity – Wiley
Published: Jun 1, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.